BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15784333)

  • 1. Bioreversible quaternary N-acyloxymethyl derivatives of the tertiary amines bupivacaine and lidocaine--synthesis, aqueous solubility and stability in buffer, human plasma and simulated intestinal fluid.
    Nielsen AB; Buur A; Larsen C
    Eur J Pharm Sci; 2005 Apr; 24(5):433-40. PubMed ID: 15784333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreversible quaternary N-acyloxymethyl derivatives of the poorly soluble tertiary amine Lu 28-179--synthesis, pharmaceutical chemical characterization and bioavailability studies in dogs.
    Nielsen AB; Buur A; Larsen C
    Eur J Pharm Sci; 2005 Dec; 26(5):421-8. PubMed ID: 16150581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unanticipated acyloxymethylation of sumatriptan indole nitrogen atom and its implications in prodrug design.
    Rodrigues T; Moreira R; Guedes RC; Iley J; Lopes F
    Arch Pharm (Weinheim); 2008 Jun; 341(6):344-50. PubMed ID: 18442019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs of thiabendazole with increased water-solubility.
    Nielsen LS; Bundgaard H; Falch E
    Acta Pharm Nord; 1992; 4(1):43-9. PubMed ID: 1515051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the combined approach of N-alkylation and salt formation to enhance aqueous solubility of tertiary amines using bupivacaine as a model drug.
    Nielsen AB; Frydenvang K; Liljefors T; Buur A; Larsen C
    Eur J Pharm Sci; 2005 Jan; 24(1):85-93. PubMed ID: 15626581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
    Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
    Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
    Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
    Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and stability of dendrimer prodrugs.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2006 Feb; 308(1-2):175-82. PubMed ID: 16384673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
    Krise JP; Zygmunt J; Georg GI; Stella VJ
    J Med Chem; 1999 Aug; 42(16):3094-100. PubMed ID: 10447953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.
    Mäntylä A; Rautio J; Nevalainen T; Keski-Rahkonen P; Vepsälainen J; Järvinen T
    Eur J Pharm Sci; 2004 Oct; 23(2):151-8. PubMed ID: 15451003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability studies of some glycolamide ester prodrugs of niflumic acid in aqueous buffers and human plasma by HPLC with UV detection.
    Talath S; Shirote PJ; Lough WJ; Gadad AK
    Arzneimittelforschung; 2006; 56(9):631-9. PubMed ID: 17063638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel clodronic acid dianhydrides as bioreversible prodrugs of clodronate.
    Ahlmark M; Vepsäläinen J; Taipale H; Niemi R; Järvinen T
    J Med Chem; 1999 Apr; 42(8):1473-6. PubMed ID: 10212134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe).
    Larsen SW; Ankersen M; Larsen C
    Eur J Pharm Sci; 2004 Aug; 22(5):399-408. PubMed ID: 15265509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrugs of cimetidine with increased lipophilicity: N-acyloxymethyl and N-alkoxycarbonyl derivatives.
    Buur A; Bundgaard H
    Acta Pharm Nord; 1991; 3(1):51-6. PubMed ID: 1854437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, enzymatic hydrolysis and physico-chemical properties of N-substituted 4-(aminomethyl)benzoate diester prodrugs of ganciclovir.
    Jensen E; Bundgaard H
    Acta Pharm Nord; 1991; 3(4):243-7. PubMed ID: 1781915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolytic reactions of thymidine 5'-o-phenyl-N-alkylphosphoramidates, models of nucleoside 5'-monophosphate prodrugs.
    Ora M; Ojanperä J; Lönnberg H
    Chemistry; 2007; 13(30):8591-9. PubMed ID: 17654626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of peptides. 19. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by N-acyloxymethylation and other means.
    Møss J; Bundgaard H
    Acta Pharm Nord; 1992; 4(4):301-8. PubMed ID: 1363462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
    Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
    J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diflunisal salts of bupivacaine, lidocaine and morphine. Use of the common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model.
    Larsen SW; Østergaard J; Poulsen SV; Schulz B; Larsen C
    Eur J Pharm Sci; 2007 Jul; 31(3-4):172-9. PubMed ID: 17462869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.